A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines

Study Identifier
GMA-BTX-CM-12-518
CT.gov Identifier
NCT01749423
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Other
Sign up for trial alerts

Study Details

Medical Condition
  • Migraine - Chronic
    • Study Drug
  • OnabotulinumtoxinA
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 65 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * History of chronic migraines * 15 or more headache days over a 30 day period * A minimum of 2 consecutive treatment cycles of 100 units onabotulinumtoxinA and a minimum of 2 consecutive treatment cycles with the onabotulinumtoxinA dosing between 155 and 195 units
    Exclusion Criteria:
    * Any treatment cycle dose of onabotulinumtoxinA greater than 200 units

    Protocol Summary

    This study will evaluate the effectiveness of OnabotulinumtoxinA to prevent headaches in patients with Chronic Migraine.

    Study Locations

    No locations found.